Table 4 Prognosis of the study population
Overall | Normal (30–60 ng/mL) | Deficient (< 30 ng/mL) | Elevated (> 60 ng/mL) | P value | |
|---|---|---|---|---|---|
(n = 1091) | (n = 284) | (n = 790) | (n = 17) | ||
Hospital mortality | 162 (14.85%) | 41 (14.44%) | 115 (14.56%) | 6 (35.29%) | 0.058 |
Length of hospital stay (days) | 17.39 (8.88–32.78) | 16.73 (8.65–28.29) | 17.86 (8.96–33.89) | 24.82 (12.73–44.77) | 0.160 |